Pharma Patient and Prescriber Audiences by Condition
Patient (DTC) and prescriber (HCP) audiences for 27 conditions across seven therapeutic areas. Every household and prescriber is scored for fit to the condition, validated against the U.S. baseline, and measured every week. At $1.50 to $3.00 CPM, these audiences are priced at approximately 50% or less of the market rate.
Find a condition 27 conditions
- Plaque psoriasis & PsAICD-10 L40 · L40.5 Immunology 27,301 treating NPIs 2.30×high-fit lift
- Rheumatoid arthritisICD-10 M05-M06 Immunology 8,718 treating NPIs 2.49×high-fit lift
- Crohn's & ulcerative colitisICD-10 K50 · K51 Immunology 23,450 treating NPIs 2.07×high-fit lift
- Axial SpA / ASICD-10 M45 · M46.8 Immunology 8,718 treating NPIs 2.23×high-fit lift
- Atopic dermatitisICD-10 L20 Immunology 24,641 treating NPIs 2.09×high-fit lift
- Asthma & COPDICD-10 J45 · J44 Respiratory & Allergy 23,329 treating NPIs 2.28×high-fit lift
- Chronic hives & IgE conditionsICD-10 L50.1 · J33 · T78.4 Respiratory & Allergy 36,090 treating NPIs 3.06×high-fit lift
- Type 2 diabetesICD-10 E11 Cardiometabolic 339,687 treating NPIs 1.65×high-fit lift
- Obesity & weight managementICD-10 E66 Cardiometabolic 12,845 treating NPIs 1.63×high-fit lift
- Heart failureICD-10 I50 Cardiometabolic 35,519 treating NPIs 2.96×high-fit lift
- High cholesterol / LDLICD-10 E78.0-E78.5 Cardiometabolic 361,414 treating NPIs 1.46×high-fit lift
- AFib stroke prevention & VTEICD-10 I48 · I26 · I82.4 Cardiometabolic 39,377 treating NPIs 3.10×high-fit lift
- ATTR-CMICD-10 E85.82 · E85.4 Cardiometabolic 35,519 treating NPIs Validatingnext quality test
- SchizophreniaICD-10 F20 Neuroscience 126,187 treating NPIs HCP-firstprescriber targeting
- Bipolar & MDD (adjunct)ICD-10 F31 · F33 Neuroscience 126,187 treating NPIs HCP-firstprescriber targeting
- MigraineICD-10 G43 Neuroscience 26,348 treating NPIs 2.77×high-fit lift
- Alzheimer's diseaseICD-10 G30 Neuroscience 43,481 treating NPIs 2.65×high-fit lift
- Multiple sclerosisICD-10 G35 Neuroscience 26,348 treating NPIs 2.25×high-fit lift
- ADHDICD-10 F90 Neuroscience 127,483 treating NPIs Validatingnext quality test
- Tardive dyskinesia & Huntington's choreaICD-10 G24.01 · G10 Neuroscience 152,535 treating NPIs Validatingnext quality test
- HIVICD-10 B20 · Z21 Infectious Disease & Vaccines 12,453 treating NPIs HCP-firstprescriber targeting
- COVID-19ICD-10 U07.1 Infectious Disease & Vaccines 1,000,647 treating NPIs 1.89×high-fit lift
- InfluenzaICD-10 J09-J11 Infectious Disease & Vaccines 1,099,412 treating NPIs 1.32×high-fit lift
- HR+/HER2- breast cancerICD-10 C50 · Z17.0 Oncology & Hematology 32,761 treating NPIs 1.82×high-fit lift
- Immuno-oncology (lung, melanoma, kidney)ICD-10 C34 · C43 · C64 Oncology & Hematology 30,755 treating NPIs 2.65×high-fit lift
- Multiple myelomaICD-10 C90.0 Oncology & Hematology 25,299 treating NPIs 3.01×high-fit lift
- Menopause hot flashes (VMS)ICD-10 N95.1 Women's Health 60,474 treating NPIs 2.37×high-fit lift
No condition matches that search. Ask us about it: we build condition audiences on request.
High-fit lift is the share of high-fit households in the Audience Quality Test audience divided by the U.S. share. HCP-first conditions lead with prescriber targeting by NPI. Validating conditions are scheduled for the next Audience Quality Test.
How the condition audiences are built
Patients (DTC)
Patient profiles come from physician-reported registries, diagnostic population surveys, and federal (CDC, CMS, NIH) and disease-association reporting. Each of 251.7M U.S. adult records is scored 0 to 100 for fit to the published profile by age, gender and income, weighted by geographic prevalence where a published source meets our standard.
Prescribers (HCP)
Treating and referring prescribers are counted by primary NUCC taxonomy in the CMS NPPES registry (September 2026) and matched to home addresses in Semcasting's NPI file for reach on CTV, streaming and display. Referring counts exclude doctors already counted as treating.
What it is not
No diagnosis records, claims, prescriptions or PHI are used, and the score says nothing about any one person's health. Quality is confirmed by comparing delivered audiences with the national panel at fixed score cutoffs, every week during a campaign.